| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.8B | $1.0B | $1.3B | $1.0B | $0.2B | $0.2B | $0.1B |
| Net Income | $0.6B | $0.6B | $0.7B | $1.0B | $0.8B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $6.16 | $5.60 | $7.04 | $9.31 | $7.22 | $1.46 | $1.36 | $0.81 |
| EPS (Diluted) | $6.12 | $5.56 | $6.97 | $9.21 | $7.14 | $1.44 | $1.35 | $0.81 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.9B | $8.3B | $8.5B | $7.8B | $6.8B | $5.9B | $5.5B | $5.1B |
| Current Assets | $1.6B | $1.8B | $2.1B | $2.2B | $2.3B | $1.8B | $1.5B | $1.5B |
| Cash & Equivalents | $0.0B | $0.0B | $0.1B | $0.1B | $0.4B | $0.3B | $0.0B | $0.0B |
| Total Liabilities | $4.4B | $4.3B | $4.4B | $4.1B | $3.7B | $3.3B | $3.2B | $3.0B |
| Current Liabilities | $1.9B | $1.7B | $1.8B | $1.6B | $1.7B | $1.1B | $1.0B | $1.4B |
| Stockholders' Equity | $3.6B | $4.0B | $4.1B | $3.7B | $3.1B | $2.6B | $2.3B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.5B | $1.7B | $1.8B | $1.2B | $1.1B | $1.1B | $1.1B |
| Investing Cash Flow | $-0.6B | $-0.7B | $-1.7B | $-1.6B | $-0.9B | $-0.6B | $-0.8B | $-0.9B |
| Capital Expenditures | $0.7B | $0.9B | $1.9B | $1.5B | $0.9B | $0.7B | $0.9B | $1.0B |
| Financing Cash Flow | $-1.1B | $-0.8B | $-0.1B | $-0.5B | $-0.3B | $-0.2B | $-0.3B | $-0.2B |